SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan
View ORCID ProfileSintaroo Watanabe, View ORCID ProfileRokuro Hama
doi: https://doi.org/10.1101/2022.10.13.22281036
Sintaroo Watanabe
1Japan Marine United Corporation, Kure Shipyard, Kure, Japan
MD, PhDRokuro Hama
2Non-profit Organization “Japan Institute of Pharmacovigilance (Med Check)”, Osaka, Japan
MD
- Supplemental[supplements/281036_file06.docx]
Posted October 18, 2022.
SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan
Sintaroo Watanabe, Rokuro Hama
medRxiv 2022.10.13.22281036; doi: https://doi.org/10.1101/2022.10.13.22281036
Subject Area
Subject Areas
- Addiction Medicine (407)
- Allergy and Immunology (718)
- Anesthesia (212)
- Cardiovascular Medicine (3025)
- Dermatology (256)
- Emergency Medicine (451)
- Epidemiology (12941)
- Forensic Medicine (12)
- Gastroenterology (844)
- Genetic and Genomic Medicine (4740)
- Geriatric Medicine (438)
- Health Economics (744)
- Health Informatics (3007)
- Health Policy (1087)
- Hematology (405)
- HIV/AIDS (950)
- Medical Education (447)
- Medical Ethics (117)
- Nephrology (487)
- Neurology (4522)
- Nursing (241)
- Nutrition (669)
- Oncology (2351)
- Ophthalmology (664)
- Orthopedics (262)
- Otolaryngology (332)
- Pain Medicine (294)
- Palliative Medicine (85)
- Pathology (511)
- Pediatrics (1224)
- Primary Care Research (513)
- Public and Global Health (7111)
- Radiology and Imaging (1578)
- Respiratory Medicine (937)
- Rheumatology (455)
- Sports Medicine (393)
- Surgery (501)
- Toxicology (63)
- Transplantation (216)
- Urology (187)